Fact CheckerSign in

NCT06323187Not yet recruiting

Optimization of Cervical Collections in Pregnancy

Source: ClinicalTrials.gov · Last updated 21 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Fetal cells are not easily obtained from pregnant patients; this curtails testing to assess the health of the fetus and the mother. Currently, the only way of diagnosing fetal genetic or chromosomal abnormalities is by invasive techniques, such as chorionic villous sampling (CVS) and amniocentesis performed at 10 to 13 weeks and after 15 weeks of gestation, respectively. Although small, there is a risk for fetal loss with these procedures. Transcervical cell sampling (TCS), similar to a Pap smear, is a platform that meets the requirements for prenatal genetic testing (genetic testing with fetal cells obtained before birth), as well as diagnosis of maternal pregnancy complication, at a very early stage of pregnancy (as early as 5 weeks) and carries low risk for the mother and the developing fetus. This study will examine cervical fluid collected using various noninvasive methods for TCS in pregnant women. The number of placental cells will be assessed against similarly obtained samples from nonpregnant women of reproductive age who lack cells derived from a placenta. Participating volunteers will provide written informed consent. Only standard medical procedures and approved devices will be used for collection of cervical fluid, minimizing risk to the participants and their fetuses. No test results or other benefits will be available to the participants.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
2600 (estimated)
First submitted
14 Mar 2024
Start date
1 May 2024
Primary completion date
28 Feb 2026
Lead sponsor
Dr. Sascha Drewlo
NCT number
NCT06323187

What you commit to

  • Study type: Observational
  • Planned participants: 2600
  • From 1 May 2024 to the primary completion date, 28 Feb 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Bleeding \>5 days in first trimester for pregnant participants

Other

  • Ruptured membranes for pregnant participants
  • Currently menstruating for non-pregnant participants

Who the study is looking for

  • Confirmed pregnancy Before 30w0d gestation for pregnant participants
  • Regular menses within previous month for non-pregnant participants
  • 18-45 years old

Age in the registry: 18 years to 45 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.